Mesothelioma Legal News

Scientist Ian Blair at the University of Pennsylvania School of Medicine believes his team is close to identifying the variant of a blood-based biomarker that could diagnose asbestos disease in its earliest stages. If successful, it could clear the path to a more treatable — and potentially curable — stage of malignant mesothelioma cancer. “This…

The post UPenn Research with Mesothelioma Blood Test Shows Promise appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

A new clinical trial is testing an innovative approach to immunotherapy that could change the way antibodies target pleural mesothelioma tumors. Researchers at eight cancer centers across the U.S. are examining the safety and efficacy of INBRX-109, a unique antibody structure developed to bind with and destroy mesothelioma tumor cells without harming healthy tissue. Enrollment…

The post Mesothelioma Clinical Trial Testing New INBRX-109 Antibody appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The U.S. Food and Drug Administration found asbestos-contaminated talc in nine of the 52 cosmetic products tested during its year-long study released this week. The products with asbestos were recalled at various times throughout the past year when individual results were obtained and the public was notified. Monday’s announcement by the FDA was labeled a…

The post FDA Tests Find Asbestos in Nine Cosmetic-Talc Products appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The Mesothelioma Applied Research Foundation has postponed its annual International Symposium on Malignant Mesothelioma next month because of the COVID-19 virus, commonly known as the novel coronavirus. The event is the largest gathering of the mesothelioma community each year. It was scheduled for April 6-7 in San Antonio, Texas. Officials with the Mesothelioma Applied Research…

The post Coronavirus Postpones Mesothelioma Symposium appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

An upcoming phase III clinical trial involving the National Cancer Institute should clarify the still-debatable benefits of using radiotherapy in combination with aggressive surgery for patients with pleural mesothelioma. The trial will be the first multicenter, randomized study measuring both safety and potential survival benefits of intensity-modulated radiation therapy (IMRT) and pencil-beam scanning with pleurectomy…

The post Study to Clarify Radiation Benefits in Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Revlon Inc. on Tuesday became the latest corporation hit with a lawsuit alleging asbestos-contaminated talc in its cosmetic products caused mesothelioma cancer in a woman. A Maryland couple filed the lawsuit in New York state court. Laura McDaniel believes her diagnosis of mesothelioma in January stems from her father’s earlier employment with Revlon, the multinational…

The post Revlon Named in Talc-Mesothelioma Lawsuit appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will measure the safety and efficacy of using two different immunotherapy drug regimens — Opdivo (nivolumab) and Yervoy (ipilimumab) — beginning 42 days before surgery. The hope is that at least one will…

The post Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer. The test has the potential to produce a much-earlier diagnosis of disease and the ability to personalize treatment and better predict a patient’s response to specific therapies….

The post Mesothelioma Detection May Come Earlier with Liquid Biopsy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase III trial, known as the INFINITE clinical research study, is designed to evaluate the intrapleural delivery of an investigational drug — a type of gene therapy — in combination with celecoxib and…

The post Gene Therapy for Mesothelioma Has ‘Real Potential’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Look at all these tropical birds!

"Buenos dias," or "buenos noches"?

Can you tell Picasso from Pissarro?

Who made these sweet rides?

Don’t go in the water!